XML 45 R33.htm IDEA: XBRL DOCUMENT v3.24.1.u1
FAIR VALUE DISCLOSURES (Tables)
3 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis
Assets and liabilities measured at fair value on a recurring basis are summarized below.
Fair Value Measurements as of March 31, 2024
Level 1
Level 2
Level 3
Total
 (in millions)
Assets:
Investments:
Fixed maturities, AFS:
Corporate (1)$ $34,334 $2,238 $36,572 
U.S. Treasury, government and agency 4,403  4,403 
States and political subdivisions 434  434 
Foreign governments 542  542 
Residential mortgage-backed (2) 1,391  1,391 
Asset-backed (3) 7,979 33 8,012 
Commercial mortgage-backed 2,962 6 2,968 
Redeemable preferred stock 59  59 
Total fixed maturities, AFS 52,104 2,277 54,381 
Other equity investments150 444 55 649 
Trading securities224 51  275 
Other invested assets:
Short-term investments 401  401 
Assets of consolidated VIEs/VOEs  3 3 
Swaps (266) (266)
Credit default swaps (2) (2)
Options 11,205  11,205 
Total other invested assets 11,338 

3 

11,341 
Cash equivalents1,813 1,043  2,856 
Purchased market risk benefits  14,689 14,689 
Assets for market risk benefits  784 784 
Separate Accounts assets (4)123,677 2,584 1 126,262 
Modco payable (5)
  (292)(292)
SCS, SIO, MSO and IUL indexed features’ asset 8,664  8,664 
Total Assets$125,864 $76,228 $17,517 $219,609 
Liabilities:
SCS, SIO, MSO and IUL indexed features’ liability (6)
 11,200  11,200 
Liabilities for market risk benefits
  12,791 12,791 
Funds withheld payable (7)
  (29)(29)
Total Liabilities$ $11,200 $12,762 $23,962 
______________
(1)Corporate fixed maturities includes both public and private issues.
(2)Includes publicly traded agency pass-through securities and collateralized obligations.
(3)Includes credit-tranched securities collateralized by sub-prime mortgages, credit risk transfer securities and other asset types.
(4)Separate Accounts assets included in the fair value hierarchy exclude investments in entities that calculate NAV per share (or its equivalent) as a practical expedient. Such investments excluded from the fair value hierarchy include investments in real estate. As of March 31, 2024 the fair value of such investments was $354 million.
(5)Reflected in Amounts due from reinsurers.
(6)SCS embedded derivative asset is recorded as a modco receivable. This is presented net in the consolidated balance sheets.
(7)As discussed in Note 2, the funds withheld payable is created through a funds withheld and modified coinsurance arrangements where the investments supporting the reinsurance agreement are withheld by and continue to reside on the Company’s consolidated balance
sheet. This embedded derivative is valued as a total return swap with references to the fair value of the invested assets held by the Company, which are primarily available for sale securities..

Fair Value Measurements as of December 31, 2023
Level 1Level 2Level 3Total
 (in millions)
Assets:
Investments:
Fixed maturities, AFS:
Corporate (1)$— $35,197 $2,070 $37,267 
U.S. Treasury, government and agency— 4,539 — 4,539 
States and political subdivisions— 443 27 470 
Foreign governments— 581 — 581 
Residential mortgage-backed (2)— 1,344 — 1,344 
Asset-backed (3)— 7,981 24 8,005 
Commercial mortgage-backed— 2,894 2,900 
Redeemable preferred stock— 59 — 59 
Total fixed maturities, AFS— 53,038 2,127 55,165 
Other equity investments150 445 54 649 
Trading securities207 50 — 257 
Other invested assets:
Short-term investments— 414 — 414 
Assets of consolidated VIEs/VOEs— — 
Swaps— (180)— (180)
Credit default swaps— (2)— (2)
Options— 9,117 — 9,117 
Total other invested assets— 9,349 9,352 
Cash equivalents1,917 616 — 2,533 
Purchased market risk benefits— — 16,729 16,729 
Assets for market risk benefits— — 574 574 
Separate Accounts assets (4)118,353 2,617 — 120,970 
Modco payable (5)
— — (411)(411)
SCS, SIO, MSO and IUL indexed features’ asset
— 7,140 — 7,140 
Total Assets$120,627 $73,255 $19,076 $212,958 
Liabilities:
SCS, SIO, MSO and IUL indexed features’ liability (6)
— 9,081 — 9,081 
Liabilities for market risk benefits— — 14,570 14,570 
Funds withheld payable (7)
— — 100 100 
Total Liabilities$— $9,081 $14,670 $23,751 
______________

1.Corporate fixed maturities includes both public and private issues.
2.Includes publicly traded agency pass-through securities and collateralized obligations.
3.Includes credit-tranched securities collateralized by sub-prime mortgages, credit risk transfer securities and other asset types.
4.Separate Accounts assets included in the fair value hierarchy exclude investments in entities that calculate NAV per share (or its equivalent) as a practical expedient. Such investments excluded from the fair value hierarchy include investments in real estate. As of December 31, 2023 the fair value of such investments was $371 million.
5.Reflected in Amounts due from reinsurers.
6.SCS embedded derivative asset is recorded as a modco receivable. This is presented net in the consolidated balance sheets.
7.As discussed in Note 2, the funds withheld payable is created through a funds withheld and modified coinsurance arrangements where the investments supporting the reinsurance agreement are withheld by and continue to reside on the Company’s consolidated balance sheet. This embedded derivative is valued as a total return swap with references to the fair value of the invested assets held by the Company, which are primarily available for sale securities.
Schedule of Reconciliation of Assets and Liabilities at Level 3
The tables below present reconciliations for all Level 3 assets and liabilities and changes in unrealized gains (losses). Not included below are the changes in balances related to market risk benefits and purchased market risk benefits level 3 assets and liabilities, which are included in Note 9 of the Notes to these Consolidated Financial Statements.
Three Months Ended March 31, 2024
CorporateState and Political SubdivisionsAsset-backedCMBS
(in millions)
Balance, beginning of period$2,070 $27 $24 $6 
Total gains and (losses), realized and unrealized, included in:
Net income (loss) as:
Net investment income (loss)2    
Investment gains (losses), net(1)   
Subtotal1    
Other comprehensive income (loss)10    
Purchases201  23  
Sales(54)   
Activity related to consolidated VIEs/VOEs    
Transfers into Level 3 (1)57    
Transfers out of Level 3 (1)(47)(27)(14) 
Balance, end of period$2,238 $ $33 $6 
Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (2)$ $ $ $ 
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (2)$10 $ $ $ 
_______________
(1)Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values.
(2)For instruments held as of March 31, 2024 amounts are included in net investment income or net derivative gains (losses) in the consolidated statements of income (loss) or unrealized gains (losses) on investments in the consolidated statements of comprehensive income.
Three Months Ended March 31, 2024
Other Equity Investments (3)Separate Accounts AssetsFunds Withheld PayableModco Payable
(in millions)
Balance, beginning of period$57 $ $100 $(411)
Realized and unrealized gains (losses), included in Net income (loss) as:
Investment gains (losses), reported in net investment income1    
Net derivative gains (losses)     
Total realized and unrealized gains (losses)1 

  

 
Other comprehensive income (loss)    
Purchases 42 1   
Sales (42)   
Change in fair value of funds withheld assets

  (129)119 
Other     
Activity related to consolidated VIEs/VOEs    
Transfers into Level 3 (1)    
Three Months Ended March 31, 2024
Other Equity Investments (3)Separate Accounts AssetsFunds Withheld PayableModco Payable
Transfers out of Level 3 (1)    
Balance, end of period$58 $1 $(29)$(292)
Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (2)$ $ $ $ 
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (2)$ $ $ $ 
_______________
(1)Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values.
(2)For instruments held as of March 31, 2024, amounts are included in net investment income or net derivative gains (losses) in the consolidated statements of income (loss) or unrealized gains (losses) on investments in the consolidated statements of comprehensive income.
(3)Other Equity Investments include other invested assets.
Three Months Ended March 31, 2023
CorporateState and Political SubdivisionsAsset-backedCMBS
(in millions)
Balance, beginning of period$2,103 $29 $— $32 
Total gains and (losses), realized and unrealized, included in:
Net income (loss) as:
Net investment income (loss)— — — 
Investment gains (losses), net(3)— — — 
Subtotal(2)— — — 
Other comprehensive income (loss)18 — — — 
Purchases143 — 12 
Sales(90)(1)— — 
Activity related to consolidated VIEs/VOEs— — — — 
Transfers into Level 3 (1)— — — — 
Transfers out of Level 3 (1)(258)— — — 
Balance, end of period$1,914 $28 $12 $34 
Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (2)$— $— $— $— 
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (2)$17 $— $— $— 
_______________
(1)Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values.
(2)For instruments held as of March 31, 2023 amounts are included in net investment income or net derivative gains (losses) in the consolidated statements of income (loss) or unrealized gains (losses) on investments in the consolidated statements of comprehensive income.
Three Months Ended March 31, 2023
Other Equity Investments (3)Separate Accounts AssetsFunds Withheld PayableModco Payable
(in millions)
Balance, beginning of period$17 $$— $— 
Realized and unrealized gains (losses), included in Net income (loss) as:
Investment gains (losses), reported in net investment income(3)— — — 
Net derivative gains (losses) — — — — 
Total realized and unrealized gains (losses)(3)

 — 

— 
Other comprehensive income (loss)— — — — 
Purchases — — — — 
Sales — — — — 
Other — — — — 
Activity related to consolidated VIEs/VOEs— — — — 
Transfers into Level 3 (1)— — — — 
Transfers out of Level 3 (1)— — — — 
Balance, end of period$14 $$— $— 
Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (2)$(3)$ $— $— 
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (2)$— $— $— $— 
_______________
(1)Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values.
(2)For instruments held as of March 31, 2023, amounts are included in net investment income or net derivative gains (losses) in the consolidated statements of income (loss) or unrealized gains (losses) on investments in the consolidated statements of comprehensive income.
(3)Other Equity Investments include other invested assets.
Schedule of Quantitative Information About Level 3 Fair Value Measurement
The following tables disclose quantitative information about Level 3 fair value measurements by category for assets and liabilities:

Quantitative Information about Level 3 Fair Value Measurements as of March 31, 2024
Fair
Value
Valuation TechniqueSignificant
Unobservable Input
RangeWeighted Average (2)
(Dollars in millions)
Assets:
Investments:
Fixed maturities, AFS:
Corporate$308 Matrix pricing model
Spread over benchmark
20 bps - 220 bps
146 bps
1,156 Market  comparable  companies
EBITDA multiples
Discount rate
Cash flow multiples
Loan to value
3.3x - 30.5x
0.0% - 19.2%
0.8x - 9.3x
0.0% - 61.4%
13.5x
3.8%
6.2x
14.0%
Fair
Value
Valuation TechniqueSignificant
Unobservable Input
RangeWeighted Average (2)
Other equity investments2 Discounted Cash Flow
Earnings multiple
3.9x - 7.0x
5.9x
Purchased MRB asset (1) (2) (4)14,689 Discounted cash flow
Lapse rates
Withdrawal rates
GMIB utilization rates
Non-performance risk
Volatility rates - equity
Mortality: Ages 0-40
Ages 41-60
Ages 61-115
0.21% - 29.37%
0.00% - 14.97%
0.04% - 100.00%
22 bps - 101 bps
12% - 28%
0.01% - 0.18%
0.07% - 0.53%
0.33% - 42.00%
2.84%
0.58%
5.24%
32 bps
23%
2.99%
(same for all ages)
(same for all ages)
Liabilities: (5)
Direct MRB (1) (2) (3) (4)$12,007 Discounted cash flow
Non-performance risk
Lapse rates
Withdrawal rates
Annuitization
Mortality (1): Ages 0-40
Ages 41-60
Ages 61-115

117 bps
0.21% - 29.37%
0.00% - 14.97%
0.04% - 100.00%
0.01% - 0.18%
0.07% - 0.53%
0.33% - 42.00%

117 bps
3.17%
0.67%
5.22%
2.79%
(same for all ages)
(same for all ages)
______________
(1)Mortality rates vary by age and demographic characteristic such as gender. Mortality rate assumptions are based on a combination of company and industry experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuating the embedded derivatives.
(2)For lapses, withdrawals, and utilizations the rates were weighted by counts, for mortality weighted average rates are shown for all ages combined and for withdrawals the weighted averages were based on an estimated split of partial withdrawal and dollar-for-dollar withdrawals.
(3)MRB liabilities are shown net of MRB assets. Net amount is made up of $12.8 billion of MRB liabilities and $784 million of MRB assets.
(4)Includes Legacy and Core products.
(5)    Funds withheld and modco payable that contain embedded derivatives held at fair value are excluded from the tables above. The funds withheld payable embedded derivative utilizes a total return swap technique which incorporates the fair value of the invested assets supporting the reinsurance agreement as a component of the valuation.
Quantitative Information about Level 3 Fair Value Measurements as of December 31, 2023
Fair
Value
Valuation Technique
Significant
Unobservable Input
Range
Weighted Average (2)
(Dollars in millions)
Assets:
Investments:
Fixed maturities, AFS:
Corporate$330 Matrix pricing model
Spread over benchmark
20 - 747 bps
187 bps
979 Market comparable companies
EBITDA multiples
Discount rate
Cash flow multiples
Loan to value
3.3x - 29.0x
0.0% - 22.8%
0.8x -10.0x
3.4%-61.0%
13.6x
3.9%
6.3x
13.8%
Other equity investmentsDiscounted cash flow
Earnings multiple
6.5x - 6.2x
6.0x
Purchased MRB asset (1) (2) (4)16,729 Discounted cash flow
Lapse rates
Withdrawal rates
GMIB utilization rates
Non-performance risk (bps)
Volatility rates - Equity
Mortality: Ages 0-40
Ages 41 - 60
Ages 61 - 115
0.21% - 29.37%
0.00%-14.97%
0.04%-100.00%
23 bps - 97 bps
11%-28%
0.01%-0.18%
0.07%-0.53%
0.33%-42.00%
2.75%
0.55%
5.51%
35 bps
23%
2.87%
(same for all ages)
(same for all ages)
Liabilities: (5)
Direct MRB (1) (2) (3) (4)$13,996 Discounted cash flow
Non-performance risk
Lapse rates
Withdrawal rates
Annuitization rates
Mortality: Ages 0-40
Ages 41 - 60
Ages 61 - 115
118 bps
0.21%-29.37%
0.00%-14.97%
0.04%-100.00%
0.01%-0.18%
0.07%-0.53%
0.33%-42.00%
118 bps
3.03%
0.64%
5.44%
2.63%
(same for all ages)
(same for all ages)
______________
(1)Mortality rates vary by age and demographic characteristic such as gender. Mortality rate assumptions are based on a combination of company and industry experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuating the embedded derivatives.
(2)Lapses and pro-rata withdrawal rates were developed as a function of the policy account value. Dollar for dollar withdrawal rates were developed as a function of the dollar for dollar threshold, the dollar for dollar limit. GMIB utilization rates were developed as a function of the GMIB benefit base.
(3)MRB liabilities are shown net of MRB assets. Net amount is made up of $14.6 billion of MRB liabilities and $574 million of MRB assets.
(4)Includes Legacy and Core products.
(5)Funds withheld and modco payable that contain embedded derivatives held at fair value are excluded from the tables above. The funds withheld payable embedded derivative utilizes a total return swap technique which incorporates the fair value of the invested assets supporting the reinsurance agreement as a component of the valuation
Schedule of Fair Value Disclosure Financial Instruments Not Carried At Fair Value
The carrying values and fair values for financial instruments not otherwise disclosed in Note 3 and Note 4 of the Notes to these Consolidated Financial Statements were as follows:
Carrying Values and Fair Values for Financial Instruments Not Otherwise Disclosed
 
Carrying
Value
Fair Value
 
Level 1
Level 2
Level 3
Total
(in millions)
March 31, 2024:
Mortgage loans on real estate$18,024 $ $ $16,250 $16,250 
Policy loans$3,693 $ $ $3,931 $3,931 
Loans to affiliates$1,900 $ $1,776 $ $1,776 
Policyholders’ liabilities: Investment contracts $1,502 $ $ $1,456 $1,456 
Funds withheld payable$9,784 $ $ $9,784 $9,784 
Modco payable (1)
$31,045 $ $ $31,045 $31,045 
FHLB funding agreements $7,168 $ $7,086 $ $7,086 
FABN funding agreements $6,252 $ $5,839 $ $5,839 
Funding agreement-backed commercial paper (FABCP)$663 $ $675 $ $675 
Separate Accounts liabilities$10,812 $ $ $10,812 $10,812 
December 31, 2023:
Mortgage loans on real estate$17,877 $— $— $16,174 $16,174 
Policy loans$3,667 $— $— $3,961 $3,961 
Loans to affiliates$1,900 $— $1,790 $— $1,790 
Policyholders’ liabilities: Investment contracts
$1,554 $— $— $1,526 $1,526 
Funds withheld payable$10,503 $— $— $10,503 $10,503 
Modco payable
$29,912 $— $— $29,912 $29,912 
FHLB funding agreements
$7,618 $— $7,567 $— $7,567 
FABN funding agreements$6,267 $— $5,840 $— $5,840 
Funding agreement-backed commercial paper (FABCP)$939 $— $948 $— $948 
Separate Accounts liabilities$10,343 $— $— $10,343 $10,343 
______________
(1)Modco payable is reported in amounts due from reinsurers in the consolidated balance sheets.